HBW Insight
Today, Germany's switch committee, the SVA, will consider an application for exemption from requirement for sildenafil in 25mg and 50mg strengths. This is the third time the switch has been put to the committee, which has rejected it twice before.
Industry’s results from October-December period start on 22 January with Procter & Gamble reporting its fiscal year 2025 second-quarter numbers and Abbott with its 2024 full-year and fourth-quarter information.
Major Europe-based consumer health players Haleon, Bayer and Reckitt feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q4 2024 results over the coming weeks.
Single-use packaging producers obligated under Oregon’s Extended Producer Responsibility law who still haven’t registered with program facilitators will struggle at this point to meet the fast-approaching material-reporting deadline, but should nonetheless jump into the process, says EPR consultant Michael Washburn.
A round-up of the latest European people moves: PAGB names new president; Enzymatica hires marketing & sales director; Marinomed strengthens supervisory board.
Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.
Developed using Datair's Ambee climate data technology, Opella’s Pollen Passport presents users with an easy to use and interactive online visualization of air quality at holiday destinations across the world.
NutriFusion adds development, innovation head; Dymatize adds tennis pro, Olympic medalist Tommy Paul to Squad; Icy Hot sponsors Unrivaled women’s hoops league; WNBA’s Stevens, Evans invest in, promote Mela Vitamins.
“We have made significant strides in finding new ways to return money to consumers, but a fix to our 13(b) authority is badly needed,” says Sam Levine.
Guest authors Rachel Raphael, partner at Morgan, Lewis & Bockius, LLP, and Elizabeth Bresnahan, an associate at the firm, advise beauty companies on how to avoid the common mistakes firms make in social media marketing and suggest proactive steps to reduce litigation risk.
Egis is the beneficiary as Teva again trims its OTC portfolio with the sale of Hungarian skin-care brand Neogranormon.
Beauty industry insiders from trade associations and attorneys specializing in marketing law and/or cosmetics manufacturing look forward to a more business-friendly FTC in the US in 2025, while they expect industry to face an increasing number of challenges at the state level. Meanwhile, the EU beauty market is hopeful it will see reduced regulations this year.
Supplement and food product firms have until January 2027 and oral drug product firms have until a year later to stop using Red No. 3, FDA decides in approving 2022 petition filed by public health advocacy groups.
Now backed by private-equity firm 21 Invest, Omega Pharma is bolstering its Italian nutraceutical portfolio through the acquistion of Inpha and its Normocis brand.
Wyoming-based NuOrganic Cosmetics agreed to comply with National Advertising Division recommendations that the firm take immediate steps to ensure any affiliates on social media platforms such as TikTok and Instagram that post on its products disclose their material connection to the brand.
Former FDA commissioners Mark McClellan and Scott Gottlieb, former acting commissioner Janet Woodcock and current commissioner Robert Califf offered advice on successfully implementing reforms and preventing a mass exodus of FDA employees as inklings emerge that the Trump team is already engaged on this front.
Cavazzoni, who led the drugs center four-and-a-half years, decided on her own to retire at this time, sources said. The decision may have been a preemptive move knowing her time as head of CDER would have been limited, or at the very least highly challenging, under the new administration.
IPA Europe responds critically to recent EU Ombudsman's decision that the EC’s position in relation to probiotics is “reasonable". “While we respect the Ombudsman’s role, its conclusions fail to address the main critical concerns raised by stakeholders,” the association insists.
Australian government finds an insufficient body of new evidence to support Rx-to-OTC switch of erectile dysfunction drug sildenafil since it was last considered in 2020.
FTC seeks comment on three proposals to “strengthen the agency’s tools to curb deceptive earnings claims in industries where they are pervasive: multi-level marketing programs and money-making opportunities.” However, Republican members say they’ll reconsider the proposals as a majority after Trump takes office.